2001 NSH Region VII & CSH meeting

From:John McGinley <mcginleyj@amc.org>


    This is the last call for the 2001 NSH Region VII & CSH meeting will be
held at Children's hospital this Friday and Saturday, April 20th & 21st. If
you have already registered thank you for your patronage. If you have not
registered, but are interested in attending the meeting, please visit our
web site at www.coloradohisto.org/program and fill out the online
registration form. You may remit payment the day of the meeting.


John McGinley, CSH Registrar
email: mailto:mcginleyj@amc.org


2001 NSH Region VII & CSH Meeting

Location: Childrenis Hospital (6th floor)
1056 E. 19 th Avenue
Denver, CO

Parking garage $1.00

Registration: Friday: Noon - 1:00
Saturday: 7:30 - 8:00

Exhibitors: Friday: 2:00 - 6:00
Saturday: 9:30 - 3:30

Friday, April 20
12:00 - 1:00 Registration
1:00 - 2:30 Class 1a or 1b
2:30 - 3:00 Break in the exhibitor area
3:00 - 4:30 Class 1c or 1d
4:30 - 6:00 Wine and Cheese
Saturday, April 21
7:30 - 8:00 Registration
8:00 - 9:30 Class 2a or 2b
9:30 - 10:00 Break in the exhibitor area
10:00 -11:30 Class 2a or 2c
11:30 - 1:00 Lunch in Exhibitor Area/CSH
1:00 - 2:30 Class 3a or 3b
2:30 - 3:00 Break in the exhibitor area
3:00 - 4:30 Class 3a or 3c

Cost: Based per session, not by workshop (there are only 3 sessions)
    Members: $25.00 per session  ($75.00 max)
Non-Members: $40.00 per session ($120.00 max)

Session 1

#1a Immunohistochemistry Update n 2001"
Richard Cartun, PhD Hartford Hospital, CT
Case studies will be used to review current ap-plications of IHC to solid
tumor identifications, prognostic markers in breast cancer, cytology, and
infectious disease detection. Use of molecular pathology methods will also
be discussed.

#1b "The Animal & Human Prion Diseases (AKA The TSEiS)"
Elizabeth S. Williams DVM, PhD, Diplomat ACVP
University of Wyoming
This presentation will review the human animal transmissible spongiform
encephalopathies (CJD,
VCJD, BSE, CWD, TME, etc.); what they are and how we diagnose them.

#1c "The Chemistry of Tissue Processing"
Jerry Fredenburgh PhD, Richard Allen
This is a workshop which consists of a discus-sion of the basic chemistry
and chemical reactions that take place during tissue processing. Also
discussed are how these chemical reactions influence the results of
processing and staining. A manual and slides will be used as teaching aids.

#1d "What the Heck is HIPAA and Why Should I Care?"
Jackie Driscoll, MT(ASCP)SM, Patient Choice
Gain a general understanding of the three main areas of focus of the new
federal regulations: electronic transaction, security and privacy. Learn how
the regula-tions may affect your work environment and your rights as a
private citizen.

Session 2

#2a "Are You Singing The Blues?"
Gayle Callis, BS, MT, HT, HTL(ASCP)
Montana State University
This is a hands on hematoxylin and eosin staining workshop using several
commercially made hematoxylin formulations. The first half will be a brief
dis-cussion of the history. Formulations and chemistry of H&E staining will
be followed by a hands-on portion. If time allows troubleshooting hints on
problems commonly encountered with the H&E will be presented.
Troubleshooting hints are part of the handout for future reference. NBF
fixed tissue sections will be supplied but  attendees may wish to stain
sections from their labs, a minimum of four slides, even though there are
seven different hematoxylins available for staining.

#2b "Application of Basic IHC Including Incorporating
new Antibodies in Your Lab"
Denise Sapier, HT, BS Dako Corporation
This workshop will focus on the basics of Immunohistochemistry to include
discussion on the election of monoclonal versus polyclonal antibodies in
routine work, and troubleshooting hints on retrieval pretreatment and
background staining. Participants will also learn how to incorporate a new
antibody or a new procedure into their laboratory routine.

#2c "Applications of Immunohistochemistry to Diagnostic
Richard Cartun, PhD Hartford Hospital, CT
This lecture will review current applications of IHC to diagnostic
hematopathology. Case studies will be used to demonstrate the use of
antibodies to CD5, CD10, CD23, ALK-1, Bcl-6, CyclinD1 and others. Tissue
pretreatments and detection systems will be discussed.

Session 3

#3a "The Her-2/neu Gene and Protein in Breast Cancer: Prognostic, Predictive
and Target of Therapy."
Diane Beaubien, Ventana
Over the last 18 months, the question in the testing labs has changed from
"should we test for Her2?" to "How should we test for Her2?" Data on the two
most common methods of testing, IHC and FISH will be dis-cussed in detail.
The Her-2/neu oncogene represents the next generation of "molecular markers"
that have the potential to be utilized for: a) prognostic factor; b)
predictive factor; and c) target of new therapies.

#3b Part 1" Organs and the Role of Fetal Stem Cells "
Gail Deutsch, MD Childrenis Hospital, Denver
There has been tremendous strides in stem cell  research in the past couple
of years. Find out how distinctly different organs emerge from
multipotential precursor cell populations in the developing murine embryo.
#3c "Tricks of the Trade" moderated by: Donna Harp, HT(ASCP) Ventana
Bring your problems and bring your solutions in this round table format.
Participants will share their experiences, thoughts and opinions on various
technical issues.

#3b Part 2 "Expression of survivin in normal, hyperplastic and neoplastic
colonic mucosa."
Roberto Gianani, MD Children's hospital, Denver

<< Previous Message | Next Message >>